InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 198052

Saturday, 11/29/2014 12:12:59 PM

Saturday, November 29, 2014 12:12:59 PM

Post# of 346050

"One patient in the benign group has as high as 12 CTCs and was later found to have MBC about 6 months later"



Now a glimpse into the future and as said earlier, whether its MDSC's and/CTC's..etc, some form of home monitoring will be coming for blood based biomarkers. Heck... monitoring for blood sugar levels is just the beginning and it must be only the beginning. The only problem advancing is it creates more paradigm shifting technologies to move forward and Big Pharma sort of likes how it has been going for years. Well 100% chemo is coming to an end and will welcome I/O Immuno-Oncology and with that, comes blood based biomarkers and home monitoring.

I mean think long and hard about blood based biomarkers and home monitoring. Its coming, that is guaranteed.... but who will control PS Targeting is not guaranteed just yet ?? Astronomical value will be in play...

Even Patrick Soon-Shiong is showing a glimpse of the future with heart monitoring and again... blood based biomarker home monitoring is not far behind.

Advanced TeleSensors Awarded Patrick Soon-Shiong Innovation Award

Nov 24, 2014


The innovative technology is the ‘un’wearable device that locks onto a person’s heart and respiration rates without physical touch of any kind, allowing free movement while health information is being displayed in real time.
...
..
Engineering plans are underway to introduce a consumer model of this technology in 2015.

http://www.advancedtelesensors.com/press-release-advanced-telesensors-awarded-patrick-soon-shiong-innovation-award/


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News